Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2021-06-01 Regulatory Filings
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
Regulatory Filings
2021-06-01 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the closing of the second tranche of a private placement financing by Voyageur Pharmaceuticals Ltd. It details the issuance of common units and flow-through units, the gross proceeds raised, commissions paid, and regulatory approvals required. There is no financial statement or detailed financial report included, only an update on capital raising activities. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other filing types.
2021-05-29 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2021-05-17 English
News release - English.pdf
Regulatory Filings
2021-05-17 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, exemptions relied upon, and compensation related to the distribution. It is a regulatory filing form used in Canada to report exempt distributions of securities. The content is not a financial report like an annual or interim report, nor is it an announcement or presentation. It is a formal regulatory filing reporting on a specific securities distribution event, which fits best under the category of Regulatory Filings (RNS).
2021-05-14 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and includes detailed information about a material change event involving Health Canada approval and a private placement financing. It references regulatory compliance under National Instrument 51-102, which governs continuous disclosure obligations for Canadian public companies. The content includes a news release about the material change and financing details, which is typical for a Material Change Report filed to disclose significant corporate events. The document is not an annual or quarterly report, audit report, or earnings release. It is not a proxy, voting result, or management change announcement. It is a regulatory filing specific to material change disclosure under Canadian securities law. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (8588 characters) and detailed content confirm it is a full filing, not just a brief announcement or certification.
2021-05-14 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.